These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 21216131)

  • 1. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
    Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
    J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
    Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
    Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAFF-driven autoimmunity requires CD19 expression.
    Fairfax KA; Tsantikos E; Figgett WA; Vincent FB; Quah PS; LePage M; Hibbs ML; Mackay F
    J Autoimmun; 2015 Aug; 62():1-10. PubMed ID: 26103922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
    Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
    J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
    Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
    Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the BAFF/APRIL system on T cell function.
    Mackay F; Leung H
    Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
    Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
    Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of B cell self-tolerance by BAFF.
    Brink R
    Semin Immunol; 2006 Oct; 18(5):276-83. PubMed ID: 16916609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAFF costimulation of Toll-like receptor-activated B-1 cells.
    Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
    Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
    Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
    Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor.
    Mackay F; Figgett WA; Saulep D; Lepage M; Hibbs ML
    Immunol Rev; 2010 Sep; 237(1):205-25. PubMed ID: 20727038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
    Enzler T; Bonizzi G; Silverman GJ; Otero DC; Widhopf GF; Anzelon-Mills A; Rickert RC; Karin M
    Immunity; 2006 Sep; 25(3):403-15. PubMed ID: 16973390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
    Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH
    Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.